- Corporate Officers - H
- Harrison Seth Loring
Insider Trading History of Harrison Seth Loring
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Harrison Seth Loring since 2008.
This trader's CIK number is 1404955.
At the time of last reporting, Harrison Seth Loring was the Director of Akero Therapeutics, Inc.. (stock ticker symbol AKRO).
Also see all insider trading activities at Akero Therapeutics, Inc..
Note that in the past
Harrison Seth Loring also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Stoke Therapeutics, Inc. (STOK) by Harrison Seth Loring
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | STOK | 375,000 | $14,625,000 | 0 | $0 | 0 | $0 |
| 2019 | STOK | 1,388,889 | $25,000,002 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Heartware Ltd (HTWR) by Harrison Seth Loring
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | HTWR | 0 | $0 | 0 | $0 | 1,500 | $0 |
| 2015 | HTWR | 0 | $0 | 0 | $0 | 1,750 | $0 |
| 2014 | HTWR | 0 | $0 | 7,909 | $785,284 | 750 | $0 |
| 2013 | HTWR | 0 | $0 | 13,118 | $1,254,080 | 833 | $0 |
| 2012 | HTWR | 0 | $0 | 384,999 | $31,571,803 | 583 | $0 |
| 2011 | HTWR | 0 | $0 | 0 | $0 | 334 | $0 |
| 2010 | HTWR | 0 | $0 | 1,000,000 | $77,855,000 | 0 | $0 |
| 2008 | HTWR | 2,000,000 | $1,029,398 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Akero Therapeutics, Inc. (AKRO) by Harrison Seth Loring
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | AKRO | 0 | $0 | 308,618 | $13,395,743 | 0 | $0 |
| 2020 | AKRO | 415,000 | $14,940,000 | 0 | $0 | 0 | $0 |
| 2019 | AKRO | 900,000 | $14,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Eledon Pharmaceuticals, Inc. (TKAI) by Harrison Seth Loring
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | TKAI | 362,500 | $5,437,500 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Harrison Seth Loring:
1. Stoke Therapeutics, Inc. (STOK)
2. Heartware Ltd (HTWR)
3. Akero Therapeutics, Inc. (AKRO)
4. Eledon Pharmaceuticals, Inc. (TKAI)
Table 1. Insider trading of Stoke Therapeutics, Inc. (STOK) by Harrison Seth Loring
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-11-24 | STOK | Buy | 375,000 | 39.00 | 14,625,000 |
| 2019-06-21 | STOK | Buy | 1,388,889 | 18.00 | 25,000,002 |
Table 2. Insider trading of Heartware Ltd (HTWR) by Harrison Seth Loring
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-01 | HTWR | Option Ex | 1,000 | .00 | 0 |
| 2016-05-01 | HTWR | Option Ex | 500 | .00 | 0 |
| 2015-05-12 | HTWR | Option Ex | 250 | .00 | 0 |
| 2015-05-01 | HTWR | Option Ex | 1,500 | .00 | 0 |
| 2014-05-12 | HTWR | Option Ex | 250 | .00 | 0 |
| 2014-05-01 | HTWR | Option Ex | 500 | .00 | 0 |
| 2014-01-06 | HTWR | Sale | 7,909 | 99.29 | 785,284 |
| 2013-07-01 | HTWR | Sale | 13,118 | 95.60 | 1,254,080 |
| 2013-05-12 | HTWR | Option Ex | 250 | .00 | 0 |
| 2013-05-04 | HTWR | Option Ex | 333 | .00 | 0 |
| 2013-05-01 | HTWR | Option Ex | 250 | .00 | 0 |
| 2012-12-14 | HTWR | Sale | 75,922 | 81.06 | 6,153,857 |
| 2012-12-12 | HTWR | Sale | 11,480 | 81.82 | 939,293 |
| 2012-12-13 | HTWR | Sale | 108,571 | 81.69 | 8,869,164 |
| 2012-12-11 | HTWR | Sale | 55,358 | 82.18 | 4,549,320 |
| 2012-12-07 | HTWR | Sale | 48,130 | 80.92 | 3,894,438 |
| 2012-12-10 | HTWR | Sale | 25,500 | 83.03 | 2,117,265 |
| 2012-07-13 | HTWR | Sale | 9,199 | 90.00 | 827,910 |
| 2012-07-16 | HTWR | Sale | 19,401 | 90.21 | 1,750,164 |
| 2012-07-12 | HTWR | Sale | 194 | 90.00 | 17,460 |
| 2012-07-03 | HTWR | Sale | 525 | 90.00 | 47,250 |
| 2012-07-02 | HTWR | Sale | 700 | 90.00 | 63,000 |
| 2012-05-12 | HTWR | Option Ex | 250 | .00 | 0 |
| 2012-05-04 | HTWR | Option Ex | 333 | .00 | 0 |
| 2012-04-26 | HTWR | Sale | 30,019 | 78.04 | 2,342,682 |
| 2011-05-04 | HTWR | Option Ex | 334 | .00 | 0 |
| 2010-12-09 | HTWR | Sale | 1,000,000 | 77.86 | 77,855,000 |
| 2008-09-10 | ASX:HTW | Buy | 18,380 | .49 | 9,006 |
| 2008-09-11 | ASX:HTW | Buy | 31,620 | .48 | 15,177 |
| 2008-09-02 | ASX:HTW | Buy | 20,000 | .49 | 9,800 |
| 2008-09-03 | ASX:HTW | Buy | 5,000 | .48 | 2,400 |
| 2008-09-01 | ASX:HTW | Buy | 25,000 | .50 | 12,500 |
| 2008-08-26 | ASX:HTW | Buy | 680,198 | .51 | 346,900 |
| 2008-08-22 | ASX:HTW | Buy | 33,649 | .53 | 17,833 |
| 2008-08-21 | ASX:HTW | Buy | 184,453 | .52 | 95,915 |
| 2008-08-20 | ASX:HTW | Buy | 101,700 | .51 | 51,867 |
| 2008-08-13 | ASX:HTW | Buy | 164,500 | .52 | 85,540 |
| 2008-08-13 | ASX:HTW | Buy | 735,500 | .52 | 382,460 |
Table 3. Insider trading of Akero Therapeutics, Inc. (AKRO) by Harrison Seth Loring
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-11-30 | AKRO | Sale | 23,131 | 47.02 | 1,087,619 |
| 2022-10-25 | AKRO | Sale | 9,421 | 44.92 | 423,153 |
| 2022-10-26 | AKRO | Sale | 137,468 | 43.98 | 6,046,392 |
| 2022-10-27 | AKRO | Sale | 138,598 | 42.13 | 5,838,579 |
| 2020-07-10 | AKRO | Buy | 415,000 | 36.00 | 14,940,000 |
| 2019-06-24 | AKRO | Buy | 900,000 | 16.00 | 14,400,000 |
Table 4. Insider trading of Eledon Pharmaceuticals, Inc. (TKAI) by Harrison Seth Loring
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-09-22 | TKAI | Buy | 362,500 | 15.00 | 5,437,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Harrison Seth Loring
(Director of Akero Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.